The Ministry of Health is advising the public that the current stock of Pfizer BioNTech COVID-19 vaccines will expire on Monday (28th February 2022). Thus, from Tuesday 1st March 2022, there will be a temporary suspension of the administration of Pfizer COVID-19 vaccines pending the arrival of a new batch of Pfizer COVID-19 vaccines in the coming week. Sinopharm and Johnson & Johnson COVID-19 vaccines will continue to be administered.
Members of the public who are eighteen (18) years of age and older, and are not pregnant, can continue to access both the Sinopharm, and Johnson & Johnson COVID-19 vaccines at all designated vaccination locations, for first, second and booster doses. The Ministry notes that any COVID-19 vaccine which has received World Health Organization (WHO) approval (Emergency Use Listing) may be used as a booster for any other approved COVID-19 vaccine. The public is reminded that:
Thus, COVID-19 vaccination for persons in categories 1 and 2 listed above will be suspended until the new stock of Pfizer COVID-19 vaccines become available. The Ministry says it will continue to update the population on this matter, as required. For accurate and up to date information on the COVID-19 Vaccination Programme, please visit the COVID-19 page of the Ministry’s website at www.health.gov.tt/covid-19 or the Ministry's social media pages. We are a small operation. If you've found our articles to be informative, please consider supporting us via PayPal or buying us a coffee. Your contribution is incredibly appreciated and goes a long way. Simply sharing our articles also helps us. Sign up for our free WhatsApp Alerts to be notified as soon as we post breaking news. NEW! Check out our Merchandise Store for high-quality t-shirts, hats and more!
0 Comments
Leave a Reply. |
AboutYouthere1 is a website focused on providing useful information, breaking news, entertainment and online shopping in Trinidad and Tobago.
AlertsSupportYouTubeContactPrivacyCategories
All
Archives
March 2024
|
© 2024 Youthere1 Enterprises. All Rights Reserved.